Validation of Serum Versus Plasma Measurements of Chromogranin A Levels in Patients With Carcinoid Tumors-Reference-Cited by-同舟云学术

Validation of Serum Versus Plasma Measurements of Chromogranin A Levels in Patients With Carcinoid Tumors

Published:2006-10 Issue:3 Volume:33 Page:250-254
ISSN:0885-3177
Container-title:Pancreas
language:en
Short-container-title:

Author:

Woltering Eugene A.,Hilton Ruth S.,Zolfoghary Christy M.,Thomson Jessica,Zietz Stanley,Go Vay Liang W.,Vinik Aaron I.,Vinik Etta,O'Dorisio Thomas M.,Mamikunian Gregg

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference16 articles.

1. Tumor markers in neuroendocrine tumors.;Eriksson;Digestion,2000

2. Chromogranin A, a marker of the therapeutic success of neuroendocrine liver metastases: preliminary report.;Sondenaa;World J Surg,2004

3. Chromogranin A as a determinant of midgut carcinoid tumor volume.;Kolby;Regul Pept,2004

4. Treatment of enterochromagranin cell carcinoids with octreotide LAR.;Fykse;Scand J Gastroenterol,2004

5. Chromogranin A: a marker of neuroendocrine tumors.;D'Herbomez;Annales de Biologie Unique,2002

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Biochemical Markers of Gastro-Entero-Pancreatic (GEP) Neuroendocrine Neoplasms (NENs);Neuroendocrine Neoplasia Management;2021

2. Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review;Frontiers in Oncology;2020-05-27

3. Serum or plasma? An old question looking for new answers;Clinical Chemistry and Laboratory Medicine (CCLM);2019-09-17

4. Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors;Cancers;2019-08-04

5. Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame;Endocrine-Related Cancer;2018-01